Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Role of various markers in rejection and survival of renal transplant. Edition No. 1

VDM Publishing House, Oct 2010, Pages: 296


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Long term survival of renal graft is still a challenge in this era of better immunosuppression.This study highlighted the role of immunological & biochemical markers involved in transplant rejection.Cell mediated immunity is the main cause of rejection in both ACR and CAN while in CAN humoral immunity is also involved along with cellular immunity. Study supports that histopathology is still a gold standard test for differentiation of rejection.SCr is still a cheap & sensitive serological marker to diagnose rejection & is equally good as ß2m.Blood cholesterol should be kept on lower side.Screening for infections such as TB,CMV & S.paratyphi should be carried out for long term survival.HLA plays crucial role in survival. Study supported that HLA A33 has protective role while HLA A23,B37,DR1,DR3,DR8,DR53 have predisposing effect for renal failure in transplant recipient.Graft survival is better for 2 HLA antigens mismatch between donor and recipient than only 5/4/3 HLA antigen mismatch between donor & recipient.Study also throws light that male donor & male recipient have better graft survival than female recipient or male recipient with female donor.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds